[ad_1]
“There really is no scientific basis to stop vaccination (AstraZeneca – BNS vaccine) at this time,” Živilė Simonaitytė told reporters on Friday.
According to her, there have been no confirmed reports of dangerous side effects from this vaccine.
“The European Medicines Agency (EMA) has released information that one or another case currently does not give any reason to believe that it is specifically related to vaccination,” said the deputy minister.
According to her, the Minister of Health Arūnas Dulkys consulted with the representatives of the European Commission responsible for the vaccination processes, the Health Ministers of Germany and Greece on this issue and agreed that the data approved by the EEA should be followed.
Ž. Simonaitytė said that vaccination with the AstraZeneca vaccine is successful in Lithuania.
“Looking at the data, we may have seen slower input from AstraZaneca, but now we don’t see any major problems with the vaccine,” he said.
“Of course, if we see that one or another priority group does not want this vaccine, we can consider other possibilities of using this vaccine (BNS for other groups). But so far we have no reason to do so, because we see that vaccination with it it is quite successful, ”said the deputy minister.
Denmark, Norway and Iceland temporarily stopped receiving the AstraZeneca vaccine this week after noticing blood clots in some people after the vaccine. Experts emphasize that the decision is preventive, since a causal link between the vaccine and these disorders has not yet been established.
Austria, Latvia, Lithuania and Luxembourg discontinued vaccination with one batch of the vaccine, following reports from Austria that a 49-year-old nurse had died from increased blood clotting after vaccination, and another woman had a pulmonary embolism . The European Medicines Agency (EMA) has already ruled out that this could be related to the vaccine.
In total, as of March 9, the EVA had received 22 reports of blood clots in vaccinated people.
Currently, three COVID-19 vaccines approved by the European Medicines Agency are used in Lithuania: Pfizer and BioNTech, Moderna and AstraZeneca. The Johnson & Johnson vaccine is being prepared for use by EVA on Thursday.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
